학술논문
A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes
Document Type
Article
Author
Rubio-Navarro, Alfonso; Gómez-Banoy, Nicolás; Stoll, Lisa; Dündar, Friederike; Mawla, Alex M.; Ma, Lunkun; Cortada, Eric; Zumbo, Paul; Li, Ang; Reiterer, Moritz; Montoya-Oviedo, Nathalia; Homan, Edwin A.; Imai, Norihiro; Gilani, Ankit; Liu, Chengyang; Naji, Ali; Yang, Boris; Chong, Angie Chi Nok; Cohen, David E.; Chen, Shuibing; Cao, Jingli; Pitt, Geoffrey S.; Huising, Mark O.; Betel, Doron; Lo, James C.
Source
Nature Cell Biology; 20230101, Issue: Preprints p1-14, 14p
Subject
Language
ISSN
14657392; 14764679
Abstract
The pancreatic islets are composed of discrete hormone-producing cells that orchestrate systemic glucose homeostasis. Here we identify subsets of beta cells using a single-cell transcriptomic approach. One subset of beta cells marked by high CD63 expression is enriched for the expression of mitochondrial metabolism genes and exhibits higher mitochondrial respiration compared with CD63lobeta cells. Human and murine pseudo-islets derived from CD63hibeta cells demonstrate enhanced glucose-stimulated insulin secretion compared with pseudo-islets from CD63lobeta cells. We show that CD63hibeta cells are diminished in mouse models of and in humans with type 2 diabetes. Finally, transplantation of pseudo-islets generated from CD63hibut not CD63lobeta cells into diabetic mice restores glucose homeostasis. These findings suggest that loss of a specific subset of beta cells may lead to diabetes. Strategies to reconstitute or maintain CD63hibeta cells may represent a potential anti-diabetic therapy.